Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orion looks to tap Japan's bioventure potential

This article was originally published in Scrip

Executive Summary

Dr Jones is one of only a handful of non-Japanese in the local pharmaceutical industry who can lay claim to having some long-term perspective on the industry, having lived in the country for around 15 years. "I now find that I've been in the industry longer than some of the Japanese executives I meet," he quipped in an interview at his Tokyo home.

Topics

Related Companies

UsernamePublicRestriction

Register

SC000892

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel